CIAM
NVAX icon

Caitong International Asset Management’s Novavax NVAX Stock Holding History

Caitong International Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$282K Buy
29,970
+12,969
+76% +$116K 0.04% 348
2026
Q1 		$138K Buy
+17,001
New +$154K 0.03% 485
2025
Q4 		– Sell
-1,333
Closed -$11.6K – 2252
2025
Q3 		$11.6K Buy
1,333
+1,271
+2,050% +$9.89K 0.01% 969
2025
Q2 		$391 Sell
62
-337
-84% -$2.23K ﹤0.01% 1735
2025
Q1 		$2.56K Sell
399
-13,977
-97% -$116K ﹤0.01% 1249
2024
Q4 		$116K Buy
+14,376
New +$139K 0.11% 204

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Caitong International Asset Management's NVAX Position: Q2 2026 in Review

Caitong International Asset Management increased its Novavax (NVAX) stake by 76% in Q2 2026, buying an estimated $116K and bringing the position to 29,970 shares worth $282K. The position accounts for 0.04% of the portfolio, ranked #348.

Caitong International Asset Management first reported a position in NVAX in Q4 2024 and has held it in 6 quarters since. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Caitong International Asset Management held 29,970 shares of Novavax worth $282K as of Q2 2026.
  • Caitong International Asset Management bought 12,969 Novavax shares in Q2 2026, an estimated $116K.
  • Novavax made up 0.04% of Caitong International Asset Management's portfolio in Q2 2026, its #348 holding.
  • Caitong International Asset Management first reported a position in Novavax in Q4 2024 and has held it in 6 quarters since.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.